Mabylon vs TippingPoint Biosciences
Mabylon vs TippingPoint Biosciences, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Mabylon is on 35/100 and TippingPoint Biosciences on 59/100.
Where each one leads
Mabylon
- funding raised: $35.8M against $14.5M
TippingPoint Biosciences
- our overall score: 59/100 against 35/100
- domain rating: 90/100 against 32/100
At a glance
| Measure | Mabylon | TippingPoint Biosciences |
|---|---|---|
| What it is | Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer. | Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer. |
| Category | Biotech, MedTech, Drug Discovery, Antibody Therapeutics | Biotech, Drug Discovery, Antibody Therapeutics, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | Not published | 2021 |
| Headquarters | Geneva, Switzerland | Cambridge, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Mabylon | TippingPoint Biosciences |
|---|---|---|
| Employees | Not published | 7 |
| Total funding | $35.8M | $14.5M |
| Latest round | Series A | Seed |
| Valuation | Not published | $1.1B |
| LinkedIn followers | Not published | 1,122 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Mabylon | TippingPoint Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 35/100 | 59/100 |
| Traction | 38/100 | 45/100 |
| Team | Not published | 60/100 |
| Search visibility | 2/100 | 38/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 32/100 | 90/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Mabylon | TippingPoint Biosciences |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Mabylon vs TippingPoint Biosciences: common questions
Which is better, Mabylon or TippingPoint Biosciences?
On our 0-100 score TippingPoint Biosciences rates higher (59/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Mabylon and TippingPoint Biosciences compare on the numbers?
Mabylon leads on funding raised ($35.8M against $14.5M). TippingPoint Biosciences leads on our overall score (59/100 against 35/100), domain rating (90/100 against 32/100).
Read the full Mabylon review and pricing or the TippingPoint Biosciences review and pricing. You can also browse other Mabylon alternatives we track.